Income from continuing operations before income taxes (2)
239
6,891
3,250
2,657
2,171
Income (loss) after income taxes
Continuing operations (2)
292
5,277
2,342
1,842
1,414
Discontinued operations
5
(124
)
(32
)
(299
)
(156
)
Net income
297
5,153
2,310
1,543
1,258
Net (income) loss attributable to noncontrolling interests (1)
(230
)
(83
)
(52
)
(67
)
5
Net income attributable to McKesson Corporation (2)
67
5,070
2,258
1,476
1,263
Financial Position
Working capital
$
451
$
1,336
$
3,366
$
3,173
$
3,221
Days sales outstanding for: (3)
Customer receivables
25
27
28
26
29
Inventories
30
30
32
31
33
Drafts and accounts payable
60
61
59
54
54
Total assets
$
60,381
$
60,969
$
56,523
$
53,870
$
51,759
Total debt, including capital lease obligations
7,880
8,545
8,114
9,844
10,594
Total McKesson stockholders’ equity (4)
9,804
11,095
8,924
8,001
8,522
Payments for property, plant and equipment
405
404
488
376
278
Acquisitions, net of cash and cash equivalents acquired
2,893
4,237
40
170
4,634
Common Share Information
Common shares outstanding at year-end
202
211
225
232
231
Shares on which earnings per common share were based
Diluted
209
223
233
235
233
Basic
208
221
230
232
229
Diluted earnings (loss) per common share attributable to McKesson Corporation (5)
Continuing operations
$
0.30
$
23.28
$
9.84
$
7.54
$
6.08
Discontinued operations
0.02
(0.55
)
(0.14
)
(1.27
)
(0.67
)
Total
0.32
22.73
9.70
6.27
5.41
Cash dividends declared
270
249
249
226
214
Cash dividends declared per common share
1.30
1.12
1.08
0.96
0.92
Book value per common share (5) (6)
48.53
52.58
39.66
34.49
36.89
Market value per common share - year-end
140.87
148.26
157.25
226.20
176.57
Supplemental Data
Debt to capital ratio (7)
40.6
%
39.2
%
43.6
%
50.3
%
55.4
%
Average McKesson stockholders’ equity (8)
$
11,016
$
9,282
$
8,688
$
8,703
$
7,803
Return on McKesson stockholders’ equity (9)
0.6
%
54.6
%
26.0
%
17.0
%
16.2
%
McKESSON CORPORATION
Footnotes to Five-Year Highlights:
(1)
Primarily reflects guaranteed dividends for 2015 and annual recurring compensation for 2016, 2017 and 2018 that McKesson became obligated to pay to the noncontrolling shareholders of McKesson Europe upon the effectiveness of the Domination Agreement in December 2014. 2018 and 2017 also include net income attributable to third-party equity interests in our consolidated entities including Vantage and ClarusONE Sourcing Services LLP, which was formed in 2017.
(2)
2018 includes non-cash goodwill impairment charges (pre-tax and after-tax) of $1,738 million for our McKesson Europe and Rexall Health reporting units. 2017 includes a pre-tax gain of $3,947 million ($3,018 million after-tax) from the contribution of our Core MTS Business in connection with Healthcare Technology Net Asset Exchange.
(3)
Based on year-end balances and sales or cost of sales for the last 90 days of the year.
(4)
Excludes noncontrolling and redeemable noncontrolling interests.
(5)
Certain computations may reflect rounding adjustments.
(6)
Represents McKesson stockholders’ equity divided by year-end common shares outstanding.
(7)
Ratio is computed as total debt divided by the sum of total debt and McKesson stockholders’ equity excluding accumulated other comprehensive income (loss).
(8)
Represents a five-quarter average of McKesson stockholders’ equity.
(9)
Ratio is computed as net income attributable to McKesson Corporation for the last four quarters, divided by a five-quarter average of McKesson stockholders’ equity.
filings.tools